Laboratory Tests for Diagnosing Pernicious Anemia
The diagnosis of pernicious anemia requires a combination of complete blood count, vitamin B12 levels, and autoantibody testing, specifically anti-intrinsic factor antibodies and anti-parietal cell antibodies. 1
Primary Diagnostic Tests
Hematologic Parameters
- Complete blood count (CBC)
- Macrocytic anemia (elevated mean corpuscular volume [MCV])
- Low hemoglobin and hematocrit
- Possible pancytopenia in severe cases 1
- Peripheral blood smear
Vitamin B12 Status
- Serum vitamin B12 levels
- Low levels (<200 pg/mL) strongly suggest deficiency
- Note: Normal B12 levels don't exclude functional deficiency 1
- Methylmalonic acid (MMA)
- Elevated in vitamin B12 deficiency
- More sensitive marker than serum B12 alone 1
- Homocysteine levels
- Elevated in both B12 and folate deficiency
- Helps differentiate from isolated folate deficiency when used with MMA 1
Autoimmune Markers
- Anti-intrinsic factor antibodies (anti-IFAB)
- Anti-parietal cell antibodies (anti-PCA)
Confirmatory Testing
Gastric Assessment
- Upper endoscopy with gastric biopsies
- Confirms presence of atrophic gastritis
- Rules out other causes of B12 deficiency
- Should be performed in newly diagnosed pernicious anemia 1
- Histopathological examination
- Corpus-predominant atrophic gastritis
- Intestinal metaplasia
- Possible neuroendocrine tumors 1
Additional Tests
- Iron studies
- Folate levels
- To rule out concurrent folate deficiency 1
- Screening for associated autoimmune disorders
- Thyroid function tests (autoimmune thyroid disease commonly coexists) 1
Diagnostic Algorithm
Initial screening:
- CBC showing macrocytic anemia
- Low serum vitamin B12 levels
Confirmatory testing:
- Anti-parietal cell antibodies (screening test)
- Anti-intrinsic factor antibodies (confirmatory test)
- MMA and homocysteine levels if B12 levels are borderline
Endoscopic evaluation:
- Upper endoscopy with biopsies to confirm atrophic gastritis
- Rule out gastric neoplasia, including neuroendocrine tumors
Associated testing:
- Screening for concurrent autoimmune disorders, particularly thyroid disease
Clinical Pearls and Pitfalls
Combined antibody testing: Using both anti-intrinsic factor and anti-parietal cell antibody tests increases diagnostic sensitivity to 86.4% 3
Pitfall: Relying solely on serum B12 levels can miss functional B12 deficiency; MMA is more sensitive 1, 5
Pitfall: Testing for intrinsic factor antibodies alone without parietal cell antibodies has limited value - only 0.47% of patients are positive for intrinsic factor antibodies alone 4
Caution: Neurological symptoms may precede hematological abnormalities; don't dismiss B12 deficiency in patients with normal CBC but neurological symptoms 6
Important: All patients with newly diagnosed pernicious anemia should undergo endoscopy to confirm corpus-predominant atrophic gastritis and rule out gastric neoplasia 1
By following this comprehensive diagnostic approach, pernicious anemia can be accurately diagnosed, allowing for appropriate vitamin B12 replacement therapy and monitoring for associated conditions.